glp-1 and dual glp-1/gip receptor agonists Dose-equivalence reference based on pivotal GLP-1/dual-agonist trials: SURMOUNT-1 (tirzepatide/Zepbound, 72 weeks) STEP-1 (subcutaneous semaglutide/Wegovy, 68 weeks) OASIS-4 (oral semaglutide/Wegovy, 64 weeks). For educational comparison only—these are glp 1 and gip agonist
Pay in 4 interest-free payments of $6.45 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 8 - Oct 13








.jpg)






:max_bytes(150000):strip_icc():focal(753x486:755x488)/Shake-Shack-storefront-cheeseburger-010126-cf5f84bd138948f9a9577a082d95b8f8.jpg)












